IRIS Accounts Production v24.3.2.46 08159703 Board of Directors 1.8.23 31.7.24 31.7.24 false true false false true false Ordinary 1.00000 Ordinary B 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh081597032023-07-31081597032024-07-31081597032023-08-012024-07-31081597032022-07-31081597032022-08-012023-07-31081597032023-07-3108159703ns15:EnglandWales2023-08-012024-07-3108159703ns14:PoundSterling2023-08-012024-07-3108159703ns10:Director12023-08-012024-07-3108159703ns10:PrivateLimitedCompanyLtd2023-08-012024-07-3108159703ns10:SmallEntities2023-08-012024-07-3108159703ns10:AuditExempt-NoAccountantsReport2023-08-012024-07-3108159703ns10:SmallCompaniesRegimeForDirectorsReport2023-08-012024-07-3108159703ns10:SmallCompaniesRegimeForAccounts2023-08-012024-07-3108159703ns10:FullAccounts2023-08-012024-07-3108159703ns10:OrdinaryShareClass12023-08-012024-07-3108159703ns10:OrdinaryShareClass22023-08-012024-07-3108159703ns10:Director22023-08-012024-07-3108159703ns10:RegisteredOffice2023-08-012024-07-3108159703ns5:CurrentFinancialInstruments2024-07-3108159703ns5:CurrentFinancialInstruments2023-07-3108159703ns5:ShareCapital2024-07-3108159703ns5:ShareCapital2023-07-3108159703ns5:RetainedEarningsAccumulatedLosses2024-07-3108159703ns5:RetainedEarningsAccumulatedLosses2023-07-3108159703ns5:PlantMachinery2023-08-012024-07-3108159703ns5:FurnitureFittings2023-08-012024-07-3108159703ns5:ComputerEquipment2023-08-012024-07-3108159703ns5:PlantMachinery2023-07-3108159703ns5:FurnitureFittings2023-07-3108159703ns5:ComputerEquipment2023-07-3108159703ns5:PlantMachinery2024-07-3108159703ns5:FurnitureFittings2024-07-3108159703ns5:ComputerEquipment2024-07-3108159703ns5:PlantMachinery2023-07-3108159703ns5:FurnitureFittings2023-07-3108159703ns5:ComputerEquipment2023-07-3108159703ns5:WithinOneYearns5:CurrentFinancialInstruments2024-07-3108159703ns5:WithinOneYearns5:CurrentFinancialInstruments2023-07-3108159703ns5:AcceleratedTaxDepreciationDeferredTax2024-07-3108159703ns5:AcceleratedTaxDepreciationDeferredTax2023-07-3108159703ns5:DeferredTaxation2023-07-3108159703ns5:DeferredTaxation2023-08-012024-07-3108159703ns5:DeferredTaxation2024-07-3108159703ns10:OrdinaryShareClass12024-07-3108159703ns10:OrdinaryShareClass22024-07-31
REGISTERED NUMBER: 08159703 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JULY 2024

FOR

MEDCOPYWRITER LIMITED

MEDCOPYWRITER LIMITED (REGISTERED NUMBER: 08159703)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


MEDCOPYWRITER LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JULY 2024







DIRECTORS: Mr N J Lamb
Mrs S M I Lamb





REGISTERED OFFICE: 23 Albion Street
CHIPPING NORTON
Oxfordshire
OX7 5BL





REGISTERED NUMBER: 08159703 (England and Wales)





ACCOUNTANTS: Bronsens
Chartered Certified Accountants
Hillside
Albion Street
Chipping Norton
Oxfordshire
OX7 5BH

MEDCOPYWRITER LIMITED (REGISTERED NUMBER: 08159703)

BALANCE SHEET
31 JULY 2024

31.7.24 31.7.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 3,134 3,941

CURRENT ASSETS
Debtors 5 15,574 8,495
Cash at bank 32,134 49,796
47,708 58,291
CREDITORS
Amounts falling due within one year 6 49,969 40,169
NET CURRENT (LIABILITIES)/ASSETS (2,261 ) 18,122
TOTAL ASSETS LESS CURRENT
LIABILITIES

873

22,063

PROVISIONS FOR LIABILITIES 8 745 806
NET ASSETS 128 21,257

CAPITAL AND RESERVES
Called up share capital 9 110 110
Retained earnings 18 21,147
SHAREHOLDERS' FUNDS 128 21,257

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21 March 2025 and were signed on its behalf by:




Mr N J Lamb - Director


MEDCOPYWRITER LIMITED (REGISTERED NUMBER: 08159703)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024

1. STATUTORY INFORMATION

Medcopywriter Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 10% on cost
Fixtures and fittings - 25% on reducing balance
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

MEDCOPYWRITER LIMITED (REGISTERED NUMBER: 08159703)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2024

4. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£    £    £    £   
COST
At 1 August 2023 13,393 4,772 14,543 32,708
Additions - - 2,061 2,061
At 31 July 2024 13,393 4,772 16,604 34,769
DEPRECIATION
At 1 August 2023 13,392 2,843 12,532 28,767
Charge for year 1 482 2,385 2,868
At 31 July 2024 13,393 3,325 14,917 31,635
NET BOOK VALUE
At 31 July 2024 - 1,447 1,687 3,134
At 31 July 2023 1 1,929 2,011 3,941

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.7.24 31.7.23
£    £   
Trade debtors 11,520 8,352
Directors' current accounts 3,744 -
Prepayments 310 143
15,574 8,495

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.7.24 31.7.23
£    £   
Tax 16,079 24,312
VAT 2,793 10,200
Other creditors 28,436 -
Directors' current accounts - 3,179
Accrued expenses 2,661 2,478
49,969 40,169

7. LEASING AGREEMENTS
Total future lease commitments payable under non-cancellable operating leases as at the Balance Sheet date amount to £12,896 (2023 £554).

8. PROVISIONS FOR LIABILITIES
31.7.24 31.7.23
£    £   
Deferred tax
Accelerated capital allowances 745 806

MEDCOPYWRITER LIMITED (REGISTERED NUMBER: 08159703)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2024

8. PROVISIONS FOR LIABILITIES - continued

Deferred
tax
£   
Balance at 1 August 2023 806
Provided during year (61 )
Balance at 31 July 2024 745

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.7.24 31.7.23
value: £    £   
100 Ordinary £1 100 100
10 Ordinary B £1 10 10
110 110

10. ULTIMATE CONTROLLING PARTY

The company was under the control of Mr N Lamb throughout the current and previous year by virtue of his shareholding.